Improvement of exercise tolerance by a long-term assisting use of the short acting beta 2 agonist (procaterol) for pulmonary rehabilitation in patients with COPD.
Not Applicable
- Conditions
- Chronic Obstructive Pulmonary DiseaseCOPD
- Registration Number
- JPRN-UMIN000009577
- Lead Sponsor
- Department of Occupational Health, Tohoku University School of Medicine,
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Not provided
Exclusion Criteria
The patients who considered to have risks for exercise test, such as coronary vascular disease, arrhythmia, and heart failure are excluded from this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Endurance shuttle walking test ;ESWT
- Secondary Outcome Measures
Name Time Method Pulmonary Function Test Borg CR-10(Category-Ratio 10) SpO2, HR Nagasaki University Respiratory ADL Questionnaire St. George's Respiratory Questionnaire